HomeNewsWorldExplained | Are new coronavirus strains cause for concern?

Explained | Are new coronavirus strains cause for concern?

Health experts in the UK and US said the strain seems to infect more easily than others, but there is no evidence yet it is more deadly.

December 22, 2020 / 15:36 IST
Story continues below Advertisement
Passengers coming from the UK through flights till December 22 midnight would be tested for COVID-19 on arrival at airports. (Image: Reuters)
Passengers coming from the UK through flights till December 22 midnight would be tested for COVID-19 on arrival at airports. (Image: Reuters)

Reports from Britain and South Africa of new coronavirus strains that seem to spread more easily are causing alarm, but virus experts say it’s unclear if that’s the case or whether they pose any concern for vaccines or cause more severe disease.

Viruses naturally evolve as they move through the population, some more than others. It’s one reason we need a fresh flu shot each year.

Story continues below Advertisement

New variants, or strains, of the virus that causes COVID-19 have been seen almost since it was first detected in China nearly a year ago.

On December 19, Prime Minister Boris Johnson announced new restrictions because of the new strain. Several European Union countries and Canada were banning or limiting some flights from the U.K. to try to limit any spread.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show